Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
LVTX LAVA Therapeutics	$1.53 -1.3%	$1.42	$0.85 ▼ $2.09	$40.25M	0.5	204,634 shs	181,479 shs
QHC Quorum Health	$0.30	$0.37	$0.22 ▼ $2.49	$10.01M	2.29	266,388 shs	N/A
RENB Renovaro	$0.24 +4.5%	$0.29	$0.22 ▼ $2.10	$41.14M	0.54	2.13 million shs	642,047 shs
SSY SunLink Health Systems	$1.12 +16.6%	$1.04	$0.62 ▼ $1.91	$7.88M	1.16	145,367 shs	243,934 shs

Beginner's Guide To Retirement Stocks

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
LVTX LAVA Therapeutics	+1.64%	+0.65%	+6.53%	+21.09%	-13.89%
QHC Quorum Health	0.00%	0.00%	0.00%	0.00%	0.00%
RENB Renovaro	-1.21%	-3.87%	-25.76%	-29.99%	-64.79%
SSY SunLink Health Systems	0.00%	+0.36%	-5.97%	+31.65%	+37.30%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
LVTX LAVA Therapeutics	1.8296 of 5 stars	3.0	5.0	0.0	0.0	1.5	0.0	0.0
QHC Quorum Health	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
RENB Renovaro	1.2634 of 5 stars	0.0	5.0	0.0	0.0	1.4	1.7	0.6
SSY SunLink Health Systems	2.4397 of 5 stars	0.0	5.0	0.0	0.0	1.9	1.7	1.9

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
LVTX LAVA Therapeutics	2.00	Hold	$2.69	75.49% Upside
QHC Quorum Health	0.00	N/A	N/A	N/A
RENB Renovaro	0.00	N/A	N/A	N/A
SSY SunLink Health Systems	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest QHC, SSY, LVTX, and RENB Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
8/5/2025	LVTX LAVA Therapeutics	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$1.50 ➝ $1.24
8/5/2025	LVTX LAVA Therapeutics	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Hold	$3.00 ➝ $1.50

(Data available from 8/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
LVTX LAVA Therapeutics	$11.98M	3.36	N/A	N/A	$0.76 per share	2.01
QHC Quorum Health	$1.88B	0.01	$0.66 per share	0.46	($2.38) per share	-0.13
RENB Renovaro	N/A	N/A	N/A	N/A	$0.89 per share	N/A
SSY SunLink Health Systems	$31.09M	0.25	N/A	N/A	$2.27 per share	0.49

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
LVTX LAVA Therapeutics	-$25.11M	-$1.05	N/A	N/A	N/A	N/A	-106.29%	-38.24%	N/A
QHC Quorum Health	-$200.25M	N/A	N/A	∞	N/A	-8.65%	N/A	-4.00%	N/A
RENB Renovaro	-$88.43M	-$0.77	N/A	∞	N/A	N/A	-60.38%	-47.04%	9/29/2025 (Estimated)
SSY SunLink Health Systems	-$1.53M	$0.24	4.66	∞	N/A	5.55%	-18.98%	-14.79%	N/A

Latest QHC, SSY, LVTX, and RENB Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/13/2025	Q2 2025	LVTX LAVA Therapeutics	-$0.28	-$0.32	-$0.04	-$0.32	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
LVTX LAVA Therapeutics	N/A	N/A	N/A	N/A	N/A
QHC Quorum Health	N/A	N/A	N/A	N/A	N/A
RENB Renovaro	N/A	N/A	N/A	N/A	N/A
SSY SunLink Health Systems	N/A	N/A	N/A	N/A	N/A

Latest QHC, SSY, LVTX, and RENB Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/21/2025	SSY SunLink Health Systems	special	$0.10			7/29/2025	7/30/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
LVTX LAVA Therapeutics	N/A	10.78	10.78
QHC Quorum Health	N/A	1.21	1.10
RENB Renovaro	N/A	0.13	0.13
SSY SunLink Health Systems	N/A	3.91	3.50

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
LVTX LAVA Therapeutics	N/A
QHC Quorum Health	58.36%
RENB Renovaro	71.41%
SSY SunLink Health Systems	23.67%

Insider Ownership

Company	Insider Ownership
LVTX LAVA Therapeutics	9.50%
QHC Quorum Health	6.10%
RENB Renovaro	0.50%
SSY SunLink Health Systems	27.90%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
LVTX LAVA Therapeutics	60	26.31 million	23.81 million	Optionable
QHC Quorum Health	11,600	32.92 million	N/A	Optionable
RENB Renovaro	20	172.12 million	171.26 million	Optionable
SSY SunLink Health Systems	1,376	7.04 million	5.08 million	Not Optionable

QHC, SSY, LVTX, and RENB Headlines

Recent News About These Companies

Sunlink Health Systems Completes Merger with Regional Health

August 14, 2025 | msn.com

SunLink Health Systems (NYSE:SSY) Trading Down 7.6% - What's Next?

August 12, 2025 | americanbankingnews.com

Regional Health Properties, Inc. and SunLink Health Systems, Inc. ...

August 4, 2025 | gurufocus.com

Regional Health Properties, Inc. and SunLink Health Systems, Inc. Announce Receipt of Shareholder Approvals for Merger

August 4, 2025 | businesswire.com

Regional Health Properties, Inc. and SunLink Health Systems, Inc. ...

August 4, 2025 | gurufocus.com

SunLink Health Systems, Inc. Adjourns Special Meeting Until August 4, 2025 and Urges Stockholders of Record as of June 20, 2025 to Vote FOR the Proposed Merger With Regional Health Properties, Inc. by August 3, 2025 at 11:59 PM EDT

July 29, 2025 | businesswire.com

A Closer Look at SunLink’s (SSY) Special Dividend

July 26, 2025 | msn.com

Sunlink Health Systems Receives NYSE American Deficiency Notice

July 26, 2025 | theglobeandmail.com

SunLink Health Systems updates on planned special cash dividend

July 24, 2025 | msn.com

SunLink Health Systems, Inc. provides an Update on Proxy Voting for the Proposed Merger with Regional Health Properties, Inc. and Urges Stockholders of Record as of June 20, 2025 to Vote FOR the Proposed Merger by July 28, 2025 at 11:59 PM EDT

July 24, 2025 | businesswire.com

SunLink Health Systems, Inc. Provides Update on Special Cash Dividend Scheduled to Be Paid Prior to SunLink's Proposed Merger with Regional Health Properties, Inc.

July 24, 2025 | businesswire.com

SunLink Health Systems, Inc Declares Special Cash Dividend Prior to with the Proposed Merger with Regional Health Properties, Inc.

July 21, 2025 | businesswire.com

SunLink Health Systems Declares 10c Special Div

July 19, 2025 | marketwatch.com

SunLink Health Systems Announces That It Received a NYSE American LLC Notice Indicating That SunLink Has Fallen Below Certain NYSE American Continued Listing ... - Morningstar

July 8, 2025 | morningstar.comM

SunLink Health Systems Announces That It Received a NYSE American LLC Notice Indicating That SunLink Has Fallen Below Certain NYSE American Continued Listing Standards

July 7, 2025 | businesswire.com

Sunlink Health Systems Extends Merger Agreement Deadline

June 23, 2025 | tipranks.com

SunLink Health Systems, Inc. Announces Fiscal 2025 Third Quarter Results

May 13, 2025 | businesswire.com

REGIONAL HEALTH PROPERTIES AND SUNLINK HEALTH SYSTEMS REVISE ALL-STOCK MERGER TRANSACTION

April 15, 2025 | markets.businessinsider.com

SunLink Health Systems, Inc. Announces Fiscal 2025 Second Quarter Results

February 12, 2025 | businesswire.com

Regional Health Properties to merge with Sunlink Health Systems

January 8, 2025 | mcknightsseniorliving.comM

New MarketBeat Followers Over Time

Media Sentiment Over Time

QHC, SSY, LVTX, and RENB Company Descriptions

LAVA Therapeutics NASDAQ:LVTX

$1.53 -0.02 (-1.29%)

Closing price 04:00 PM Eastern

Extended Trading

$1.53 0.00 (0.00%)

As of 04:10 PM Eastern

LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer patients. Its lead clinical-stage candidates are LAVA-1207 that is in Phase 1/2a clinical trial for metastatic castration-resistant prostate cancer. The company is developing other Gammabody drug candidates, which include LAVA-1223, which targets the epidermal growth factor receptor (EGFR) for the treatment of selected solid tumors, as well as LAVA-1266 which are preclinical candidates for the treatment of various hematologic malignancies. LAVA Therapeutics N.V. has a research collaboration and license agreement with Janssen Biotech, Inc. for the potential discovery and development of multi-specific antibody products that are directed to a specified target in various fields of use; and a collaboration with Merck & Co., Inc. to evaluate anti-PD-1 therapy KEYTRUDA in combination with LAVA-1207. LAVA Therapeutics N.V. was incorporated in 2016 and is headquartered in Utrecht, the Netherlands.

Quorum Health NYSE:QHC

Quorum Health Corporation, together with its subsidiaries, provides hospital and outpatient healthcare services in the United States. Its hospital and outpatient healthcare services include general and acute care, emergency room, general and specialty surgery, critical care, internal medicine, diagnostic, obstetric, psychiatric, and rehabilitation services. Quorum Health Corporation offers its healthcare services through its hospitals and affiliated facilities, including urgent care centers, diagnostic and imaging centers, physician clinics, and surgery centers. The company, through its subsidiary, Quorum Health Resources, LLC, provides hospital management advisory, healthcare consulting, and group purchasing services to non-affiliated hospitals, as well as Web-based applications and software tools; and various education programs for healthcare leaders, professionals, and other medical staff. As of December 31, 2018, it owned or leased 27 hospitals with approximately 2,604 licensed beds. The company was incorporated in 2015 and is headquartered in Brentwood, Tennessee.

Renovaro NASDAQ:RENB

$0.24 +0.01 (+4.46%)

Closing price 04:00 PM Eastern

Extended Trading

$0.24 0.00 (0.00%)

As of 04:30 PM Eastern

Renovaro Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), and cancer in the United States. The company's product pipeline includes RENB-HV-01 for autologous HIV curative treatment; RENB-HV-12, a therapeutic HIV vaccine; and RENB-HB-01, a gene therapy curative treatment for HBV. It also develops RENB-DC-11, an allogeneic dendritic cell therapeutic vaccine for pancreatic cancer; RENB-DC-12-XX, an allogeneic dendritic cell therapeutic vaccine for other solid tumors; and RENB-HV-21 for treating HIV with allogeneic natural killer (NK) and gamma delta T-cells. It has strategic partnerships with the University of California, Fred Hutchinson Cancer Research Center, and Caring Cross. The company was formerly known as Renovaro Biosciences Inc. and changed its name to Renovaro Inc. in February 2024. Renovaro Inc. is headquartered in Los Angeles, California.

SunLink Health Systems NYSE:SSY

$1.12 +0.16 (+16.56%)

Closing price 08/14/2025

Extended Trading

$1.12 0.00 (0.00%)

As of 08/14/2025 08:00 PM Eastern

SunLink Health Systems, Inc., through its subsidiaries, provides healthcare products and services in the southeastern United States. It operates in two segments, Healthcare Services and Pharmacy. The Healthcare Services segment owns and operates a 49-licensed-bed acute care hospital, which includes a 26-bed geriatric psychiatry unit; two clinics; and a 66-bed extended care and rehabilitation centre. This segment also provides information technology services; and owns five acers unimproved lands. The Pharmacy segment offers institutional pharmacy services consisting of provision of specialty and non-specialty pharmaceutical and biological products, such as nursing homes, assisted living facilities, behavioural and specialty hospitals, hospices, and correctional facilities; non-institutional pharmacy services, including private residences; and durable medical equipment products and services, including the sale and rental of products for institutional clients or to patients in institutional settings and patient-administered home care, as well as retails pharmacy products and services. SunLink Health Systems, Inc. was incorporated in 1959 and is based in Atlanta, Georgia.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time